New Jersey A 6209: Improves access to lower-cost generic and biosimilar drugs.

Status: Introduced in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee (as of 2025-12-08)

State: New Jersey · Session: 221 · Bill: A 6209

Subjects: PHARMACEUTIC

Sponsors: Freiman, Roy

View New Jersey A 6209 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.